4.8 Review

Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor

期刊

CELL RESEARCH
卷 18, 期 4, 页码 452-457

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cr.2008.43

关键词

Raf Kinase; metastasis; signal transduction; inhibitor

资金

  1. NCI NIH HHS [CA112310] Funding Source: Medline
  2. NINDS NIH HHS [NS33858] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [R01CA112310] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Cells have a multitude of controls to maintain their integrity and prevent random switching from one biological state to another. Raf Kinase Inhibitory Protein (RKIP), a member of the phosphatidylethanolamine binding protein (PEBP) family, is representative of a new class of modulators of signaling cascades that function to maintain the yin yang or balance of biological systems. RKIP inhibits MAP kinase (Raf-MEK-ERK), G protein-coupled receptor (GPCR) kinase and NF kappa B signaling cascades. Because RKIP targets different kinases dependent upon its state of phosphorylation, RKIP also acts to integrate crosstalk initiated by multiple environmental stimuli. Loss or depletion of RKIP results in disruption of the normal cellular stasis and can lead to chromosomal abnormalities and disease states such as cancer. Since RKIP and the PEBP family have been reviewed previously, the goal of this analysis is to provide an update and highlight some of the unique features of RKIP that make it a critical player in the regulation of cellular signaling processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据